Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Casi Pharmaceuticals Inc (CASI)  
$1.63 0.00 (0.00%) as of 4:30 Mon 3/20


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,940,000
Market Cap: 202.02(M)
Last Volume: 38,851 Avg Vol: 19,585
52 Week Range: $1.63 - $1.63
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world.. In China, Co.'s first commercial product, EVOMELA® is approved for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The other core hematology/oncology assets in our pipeline include: CNCT19, which is being developed as a potential treatment for patients with hematological malignancies which express CD19 including, B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 459,671
Total Buy Value $0 $0 $0 $1,587,610
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 14
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 83
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Capitelli Sara B VP Fin & Principal Account Off   •       –      –    2018-04-12 4 D $6.62 $124,310 D/D (18,778) 0     -
   Capitelli Sara B VP Fin & Principal Account Off   •       –      –    2018-04-12 4 D $6.62 $54,284 D/D (8,200) 18,778     -
   Capitelli Sara B VP Fin & Principal Account Off   •       –      –    2018-04-12 4 OE $0.88 $23,741 D/D 26,978 26,978     -
   Huang James Director   –       •      –    2018-04-04 4 A $0.00 $0 D/D 191 191     -
   Huang James Director   –       •      –    2018-04-04 4 D $0.00 $0 I/I (416,666) 0     -
   Zhou Quan Director   –       •       •   2018-03-21 4 B $3.19 $651,781 I/I 204,320 646,995 2.25     -
   Zhou Quan Director   –       •       •   2018-03-21 4 B $3.19 $9,193,893 D/D 2,882,098 9,126,375 3.92     -
   He Wei-Wu Director   –       •       •   2018-03-19 4 B $3.24 $9,999,998 I/I 3,086,419 4,958,024 2.25     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2017-12-22 4 B $0.01 $6,117 I/I 611,740 4,650,262 1.5     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2017-12-22 4 B $0.01 $9,074 D/D 907,356 6,897,413 2.37     -
   He Wei-Wu Director   –       •      –    2017-10-10 4 B $1.95 $195,000 D/D 100,000 847,527 2.39     -
   He Wei-Wu Director   –       •      –    2017-10-06 4 B $1.86 $186,000 D/D 100,000 747,527 2.39     -
   He Wei-Wu Director   –       •      –    2017-10-05 4 B $1.80 $180,000 D/D 100,000 647,527 2.39     -
   He Wei-Wu Director   –       •      –    2017-09-19 4 B $1.78 $60,524 D/D 34,002 547,527 2.39     -
   He Wei-Wu Director   –       •      –    2017-09-18 4 B $1.75 $303,625 D/D 173,500 513,525 2.39     -
   He Wei-Wu Director   –       •      –    2017-09-15 4 B $1.49 $190,276 D/D 127,702 340,025 2.39     -
   He Wei-Wu Director   –       •      –    2017-09-14 4 B $1.22 $228,903 D/D 187,625 212,323 2.39     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-10-28 4 B $0.01 $7,205 I/I 720,457 4,038,522 1.5     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-10-28 4 B $0.01 $10,686 D/D 1,068,605 5,990,057 2.37     -
   He Wei-Wu Director   –       •      –    2016-10-03 4 B $1.19 $2,227,210 I/I 1,871,605 1,871,605 2.1     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-07-20 4 B $0.01 $663 I/I 66,255 3,318,065 1.42     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-07-20 4 B $0.01 $983 D/D 98,271 4,921,452 2.37     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-07-14 4 B $0.01 $3,949 I/I 394,942 3,251,810 1.42     -
   Spectrum Pharmaceuticals Cayman, L.p. 10% Owner   –       –       •   2016-07-14 4 B $0.01 $5,858 D/D 585,790 4,823,181 2.37     -
   Shong Hugo 10% Owner   –       –       •   2016-06-24 4 B $1.19 $4,467,087 D/D 3,753,855 8,498,765 2.45     -
  83 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us